Catalyst Wire Dossier Catalyst Wire Dossier

Gerilimzumab

gerilimzumab · Bird Rock Bio, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Gerilimzumab, covering 2018-07-11 to 2018-07-11. Get the full timeline:

Most recent: Clinical Trial Update: Study Evaluating Gerilimzumab´s Safety/Efficacy for Patients MTX or TNFα Antagonist Failed in Rheumatoid Arthritis [Phase 2]

See pricing